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LCriminal Law NotesJ
by F. Thomas Schornhorst
One of the more intriguing ques-
Lions working its way up through In-
diana courts is whether the state was
without any criminal law relating to
the sale, possession or use of mari-
juana, lysergic acid diethylamide
(LSD) and other non-narcotic drugs
from 2 p.m. July 26, 1973 (the pro-
mulgation date of the Indiana Acts of
1973) to 12:01 a.m., October 1, 1973,
(the effective date of the Uniform
Controlled Substances Act, IC 1971,
35-24.1, Burns §§ 10-3558 et seq.
(Supp. 1973)).
During the 1973 session the Gen-
eral Assembly moved to consolidate
the penal law coverage of narcotics
and other dangerous drugs in a single
act. Coverage had been split between
(1) the Uniform Narcotic Drug Act
(IC 1971, 35-24-1, Burns §§ 10-3519 et
seq.) dealing with the opiates and co-
caine, and (2) the Dangerous Drug
Act (IC 1971, 16-6-8, Burns §§ 35-3331
et seq.) covering, among other things,
marijuana and LSD.
Here's what happened. The legisla-
ture amended the Dangerous Drug
Act by striking from the definition of
"dangerous drug" the following sub-
sections: "(4) any hallucinogenic, psy-
chedelic, psychogenic drug or sub-
stance including but not limited to
cannabis [marijuana] or . . . LSD;
or (5) any drug appearing on the lists
of drugs under Schedules I, II, III
and IV of the Controlled Substance
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Act [21 U.S.C. § 812], and an) drugs
included therein by duly promul-
gated regulation." Coverage of these
items was provided in the Uniform
Controlled Substances Act, supra, that
was passed during the same session.
But the two actions did not mesh.
The amendment of the Dangerous
Drug Act became effective with the
promulgation of the 1973 Acts on
July 26. However, Section 7 of the
Controlled Substances Act stipulated
that the new law would not go into
effect until October 1, and the sav-
ings clause of the Controlled Sub-
stances Act referred only to the re-
pealed Uniform Narcotic Drug Act.
Criminal Law Hiatus Results
The inescapable result was a hiatus
in the criminal law with regard to a
variety of non-narcotic drugs. Instead
of a legislative remedy for this serious
oversight, a cure was sought by caus-
ing the State Board of Pharmacy to
issue a rule declaring marijuana, LSD,
and other "controlled substances" to
be dangerous drugs. The asserted
authority for this action was the pro-
vision in a section of the Dangerous
Drug Act which delegated to the
Board of Pharmacy power to include
within the dangerous drug definition
"any substance which the [Board],
after reasonable notice and hearing,
shall by promulgated rule determine
has qualities similar to that of any
dangerous drug." IC 1971, 16-6-8-2(j),
Burns § 35-33320). This language is
contained in the same section which,
prior to July 26, 1973, specifically in-
cluded marijuana, LSD, etc., within
the dangerous drug definition, and
which after July 26, was amended to
exclude those substances.
Fine print notice of the required
hearing on the proposed rule was
published in a single issue of the In-
dianapolis Star on June 13, 1973.
The notice recited that at its regular
meeting on June 11, 1973, the Board
of Pharmacy prepared and approved
a new proposed rule (No. 27) concern-
ing "proposed clarification of defini-
tions in the Dangerous Drug Act."
Nothing was revealed as to the nature
of the "clarification" that was to be
made. Hearing was set for 2 p.m., on
June 26, 1973.
At this point a potentially serious
discrepancy appears in the records of
the proceedings. Although the notice
specified the hearing date to be June
26, 1973, the minutes of the Board of
Pharmacy dated Monday, June 25,
1973, contain the following entry un-
der the heading INFORMAL HEAR-
INGS: "Rule No. 27 There he [sic]
no one present to offer any objections
to this regulation, the Board hereby
unanimously approved said rule No.
27 and submits same to the Office of
the Attorney General. (Six copies, as
required by law, were sent to the
Attorney General's office June 26,
1973)." The text of the Rule recites
that it was adopted at a regular meet-
ing held on June 26, but the minutes
indicate otherwise.
A Contradictory Result
The Rule as proposed and adopted
states: "Pursuant to the powers
granted to the Board by IC 1971, 16-6-
8-2(j), as amended by Indiana Acts
of 1971, P.L. 212, Section 1, and after
reasonable notice and hearing, the
Board hereby finds that the following
substances have qualities similar to
those of any dangerous drug," and
then goes on to include precisely the
same language with respect to mari-
juana, LSD and other drugs that the
legislature had undertaken to remove
from the same section from which the
Board purported to draw its author-
ity.
It was provided also that the rule
would expire on October 1, 1973, or
on the date of promulgation of the
1973 Acts, if later than October 1.
The provision for an expiration date
beyond October 1, 1973, tied to the
effective date of the 1973 Act seems
as superfluous as would be the rule
itself before that date. Since the
amendment deleting marijuana and
other drugs from the Dangerous Drug
Act would not have become law until
the pronulgation date, Rule 27 would
have been totally redundant until the
amendment took effect.
(Continued on page 19)
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Numerous Questions Unanswered
This leaves us with the question
whether Rule 27 was effective to pre-
serve criminal penalties with regard
to the drugs mentioned therein dur-
ing the period of the legislatively cre-
ated hiatus--July 26 to October 1,
1973. Courts responding to this ques-
tion will have to deal with the follow-
ing questions:
1. Was it a valid exercise of admin-
istrative rule-making authority to
place within the coverage of a
criminal statute substances which
the legislature expressly removed?
2. Since the statute authorizes the
Board of Pharmacy to declare sub-
stances to be dangerous drugs only
if they have "qualities similar to
that of any dangerous drug," is
the Board required to examine
available scientific evidence re-
garding a drug alleged to be dan-
gerous (e.g., marijuana) and base
its finding on such evidence?
3. INfay the Board, as it apparently
did with Rule 27, regard the ab-
sence of stated opposition to the
rule as sufficient basis for its adop-
tion?
4. Did the Board, as it must, adhere
to the legislative criteria that de-
limit its rule-making authority?
5. Did the Board act in good faith?
6. Was the notice and hearing pro-
vided "reasonable" as required by
IC 1971, 16-6-8-1(0), Burns 35-3332
(j) (Supp. 1973)? Does the inclu-
sion of the word "reasonable" in
this section require more than
minimal, pro forma compliance
with the administrative rule-mak-
ing notice requirements of IC
1971, 4-22-2-4, Burns § 60-1504?
7. Is Rule 27 valid if, as revealed
by the Board's minutes, it was
adopted (in default of opposition)
on June 25, when the only pub-
lished notice set the hearing date
for June 26?
8. Is it ever appropriate for the legis-
lature to delegate to an adminis-
trative board power to create new
felonies?
While these questions probably do
not exhaust the considerations that
must go into an examination of Rule
27, they suggest that the state will
have a difficult time defending the
Board of Pharmacy action against the
attacks that are sure to come.
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